TY - JOUR
T1 - Influence of ghrelin on the central serotonergic signaling system in mice
AU - Hansson, Caroline
AU - Alvarez-Crespo, Mayte
AU - Taube, Magdalena
AU - Skibicka, Karolina P.
AU - Schmidt, Linnéa
AU - Karlsson-Lindahl, Linda
AU - Egecioglu, Emil
AU - Nissbrandt, Hans
AU - Dickson, Suzanne L.
N1 - Funding Information:
This work was primarily supported by NeuroFAST ( FP7-KBBE-2009-3-245009 to S.L.D.) but also by additional European Commission Seventh Framework grants ( FP7-KBBE-2010-4-266408 , Full4Health and FP7-HEALTH-2009-241592 , EurOCHIP; both to S.L.D.), the Swedish Research Council for Medicine ( 2010-12208 to HN, 2011-3054 to KPS and 2012-1758 to SLD), Forskning och Utvecklingsarbete/Avtal om Läkarutbildning och Forskning Göteborg ( ALFGBG-138741 to S.L.D.), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research ( A305–188 ), and NovoNordisk Fonden (to S.L.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also thank the Genomics Core Facility platform at the Sahlgrenska Academy, University of Gothenburg, which was funded by a grant from the Knut and Alice Wallenberg Foundation.
PY - 2014/4
Y1 - 2014/4
N2 - The central ghrelin signaling system engages key pathways of importance for feeding control, recently shown to include those engaged in anxiety-like behavior in rodents. Here we sought to determine whether ghrelin impacts on the central serotonin system, which has an important role in anxiety. We focused on two brain areas, the amygdala (of importance for the mediation of fear and anxiety) and the dorsal raphe (i.e. the site of origin of major afferent serotonin pathways, including those that project to the amygdala). In these brain areas, we measured serotonergic turnover (using HPLC) and the mRNA expression of a number of serotonin-related genes (using real-time PCR). We found that acute central administration of ghrelin to mice increased the serotonergic turnover in the amygdala. It also increased the mRNA expression of a number of serotonin receptors, both in the amygdala and in the dorsal raphe. Studies in ghrelin receptor (GHS-R1A) knock-out mice showed a decreased mRNA expression of serotonergic receptors in both the amygdala and the dorsal raphe, relative to their wild-type littermates. We conclude that the central serotonin system is a target for ghrelin, providing a candidate neurochemical substrate of importance for ghrelin's effects on mood.
AB - The central ghrelin signaling system engages key pathways of importance for feeding control, recently shown to include those engaged in anxiety-like behavior in rodents. Here we sought to determine whether ghrelin impacts on the central serotonin system, which has an important role in anxiety. We focused on two brain areas, the amygdala (of importance for the mediation of fear and anxiety) and the dorsal raphe (i.e. the site of origin of major afferent serotonin pathways, including those that project to the amygdala). In these brain areas, we measured serotonergic turnover (using HPLC) and the mRNA expression of a number of serotonin-related genes (using real-time PCR). We found that acute central administration of ghrelin to mice increased the serotonergic turnover in the amygdala. It also increased the mRNA expression of a number of serotonin receptors, both in the amygdala and in the dorsal raphe. Studies in ghrelin receptor (GHS-R1A) knock-out mice showed a decreased mRNA expression of serotonergic receptors in both the amygdala and the dorsal raphe, relative to their wild-type littermates. We conclude that the central serotonin system is a target for ghrelin, providing a candidate neurochemical substrate of importance for ghrelin's effects on mood.
UR - http://www.scopus.com/inward/record.url?scp=84892632484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892632484&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2013.12.012
DO - 10.1016/j.neuropharm.2013.12.012
M3 - Article
C2 - 24373901
AN - SCOPUS:84892632484
SN - 0028-3908
VL - 79
SP - 498
EP - 505
JO - Neuropharmacology
JF - Neuropharmacology
ER -